Oppenheimer analyst Hartaj Singh lowered the price target on Inovio Pharmaceuticals (NASDAQ: INO) to $30.00 (from $35.00) while maintaining an ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Inovio Pharmaceuticals (INO) PT Lowered to $3 at StifelMarch 2, 2022 9:45 AM Inovio Pharmaceuticals (INO) PT Lowered to $5 at RBC CapitalMarch 2, 2022 6:37 AM Inovio Pharma (INO) Misses Q4 EPS by $1.13March 1, 2022 4:33 PM INOVIO Reports Fourth Quarter 2021 and Year-End Financial ResultsMarch 1, 2022 4:05 PM